Tobias Meischl

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Replacement Therapy

Ejection Fraction

Top Venues

United European gastroenterology journal

Journal of hepatocellular carcinoma

This page only lists publications with an associated author ORCID identifier.

Publications

Katharina Pomej, Lorenz Balcar, Sabrina Sidali, Riccardo Sartoris, Tobias Meischl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Maxime Ronot, Mohamed Bouattour, Matthias Pinter, Bernhard Scheiner
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma. United European gastroenterology journal (2024)
Lorenz Balcar, David Josef Maria Bauer, Katharina Pomej, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Bernhard Scheiner, Matthias Pinter
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients. PloS one 18 (4) (2023)
Katharina Pomej, Lorenz Balcar, Bernhard Scheiner, Georg Semmler, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael Trauner, Matthias Pinter
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Journal of hepatocellular carcinoma 8 (2021)
Tobias Meischl, Susanne Rasoul-Rockenschaub, Georg Győri, Bernhard Scheiner, Michael Trauner, Thomas Soliman, Gabriela A Berlakovich, Matthias Pinter
Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma. United European gastroenterology journal 9 (2) (2021)
Katharina Pomej, Bernhard Scheiner, Lukas Hartl, Lorenz Balcar, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael Trauner, Matthias Pinter
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital. PloS one 16 (8) (2021)
Nataliya Rohr-Udilova, Kaoru Tsuchiya, Gerald Timelthaler, Martina Salzmann, Tobias Meischl, Katharina Wöran, Judith Stift, Merima Herac, Rolf Schulte-Hermann, Markus Peck-Radosavljevic, Wolfgang Sieghart, Robert Eferl, Erika Jensen-Jarolim, Michael Trauner, Matthias Pinter
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Hepatology communications 5 (11) (2021)
Katharina Pomej, Bernhard Scheiner, Dabin Park, David Bauer, Lorenz Balcar, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael Trauner, Matthias Pinter
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers 12 (10) (2020)
Tobias Meischl, Susanne Rasoul-Rockenschaub, Georg Györi, Wolfgang Sieghart, Thomas Reiberger, Michael Trauner, Thomas Soliman, Gabriela Berlakovich, Matthias Pinter
C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation. PloS one 14 (5) (2019)